In vivo efficacy study of quinine sulphate in the treatment of uncomplicated P. Falciparum malaria in patients from Southwestern Cameroon

East African Medical Journal

Volumn 82, Issue 4, 2005, Pages 181-185

  Achidi, E A ^a   Ajua, A ^a   Kimbi, H K ^a   Sinju, C M ^b  

^a UNIVERSITY OF BUEA   (Cameroon)

^b Buea Provincial Hospital   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; QUININE;

ADOLESCENT; ADULT; ARTICLE; CAMEROON; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; INFANT; LONGITUDINAL STUDY; MALARIA FALCIPARUM; MALE; MIDDLE AGED; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMALARIALS; CAMEROON; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; QUININE; TREATMENT OUTCOME;

EID: 26944433841     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Watt, G., Long., Padre, L. P., Sangalang, R. and Ranoa, C.P. Chloroquine and quinine: a randomised, double blind comparison of efficacy and side effects in the treatment of P. falciparum malaria in the Phillipines. Trans. R. Soc. Trop. Med. Hyg. 1988; 82:205-208.
2. Brasseur, P., Kouamouo, J., Brandicourt, O. et al. Patterns of in vitro resistance to Chloroquine, quinine and mefloquine of P. falciparum in Cameroon. J. Trop. Med. Hyg. 1988; 39:166-172.
3. Louis, J., Louise, F., Trebuq, A. et al. Chemoresistance of P. falciparum in Central Africa. Lancet. 1992; 340:610-611.
4. Kimbi, H. K. Studies on chloroquine-resistant Plasmodium falciparum in Nigerians and Cameroonian and Plasmodium yoelli nigeriensis in mice, Ph.D. Thesis, University of Lagos, pp. 261. 1991.
5. Soula, G., Ndounga, M., Foumane, V. et al. Bilan de la resistance de Plasmodium falciparum a la chloroquine au Cameroun et alternatives therapeutiques. OCEAC. 2000; 33:13-22.
6. Titanji, V. P. K., Akenji, T., Ntopi, W., and Djokam, R. Reduced level of chloroquine resistance P. falciparum in selected foci of the South West Province, Cameroon. Cent. Afr. J. Med. 2001; 47:145-149.
7. WHO (2003). Africa Malaria Report 2003. WHO Document no. WHO/CDS/MAL/2003.1093. 112pp.
8. WHO. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL/96. 1077. WHO, Geneva. 1996
9. Bijl, H. M., Kager, J., Koetsier, D.W. and Nerf, T. Chloroquine and sulphadoxine pyrimethamine-resistant falciparum malaria in vivo - a pilot study in rural Zambia. Trop. Med. Int. Hlth. 2000; 5:692-695.
10. Agnamey, P., Moyou, S. R., Brasseur, P. and Galega, P. F. In vitro sensitivity of P. falciparum to chloroquine, amodiaquine, quinine and pyronardine. Med. Trop. 2002; 62:141-144.
11. Rahman, M. R., Dulal, C. P., Rashid, M. et al. A randomised controlled trial on the efficacy of alternative treatment regimens for uncomplicated falciparum malaria in a multidrug-resistant falciparum area of Bangladesh - narrowing the options for the National Malaria Control Programme? Trans. R. Soc. Trop. Med. Hyg. 2001; 95:661-667.
12. Ouedraogo, J. B., Dutheil, Y., Tinto, H., et al. In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa). Trop. Med. Int. Hlth. 1998; 3:381-384.
13. Ache, A., Escorihuela, M., Vivas, E. et al. In vivo drug resistance of falciparum malaria in mining areas of Venezuela. Trop. Med. Int. Hlth. 2002; 7:737-743.
14. Knowles, G., Davidson, W.L., Jolley, D. and Alpers, M.P. The relationship between the in vitro response of P. falciparum to chloroquine, quinine and mefloquine. Trans. R. Soc. Trop. Med. Hyg. 1984; 78:146-150.
15. Warsame, M., Wernsdorfer, W. H., Payne, D. and Bjorkman A. Susceptibility of P. falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine/pyrimethamjne in Somalia: relationships between the response to different drugs. Trans. R. Soc. Trop. Med. Hyg. 1991; 85:565-569.
16. Oduola, A. M. J., Moyou-Somo, R. S., Kyle, D. E. et al. Chloroquine resistant P. falciparum in indigenous residents of Cameroon. Trans. R. Soc. Trop. Med. Hyg. 1989; 83:308-310.
17. Premji, Z., Makwaya, C. and Minjas, J. N. Current clinical efficacy of chloroquine for the treatment of P. falciparum infections in Urban Dar es Salaam, United Republic of Tanzania. Bull. Wld. Hlth. Org. 1999; 77:740-744.
18. Achidi, E. A., Salimonu, L. S., Asuzu, M. C. Studies on P. falciparum parasitemia and development of anaemia in Nigerian infants during their first year of life. Amer. J. Trop. Med. Hyg. 1996; 55:138-143.
19. Bjorkman, A. Drug resistance - changing patterns. In: Malaria: waiting for the vaccine. Targett, G.A.T. (editor) Chichester: John Wiley and sons. 1991; 105-120.
20. McGready, R., Cho, I., Villegas L. Randomised comparison of quinine - clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. 2001; 95:657-656.
21. Vaillant, M., Millet, O., Luty, A. et al. Therapeutic efficacy of clindamycin in combination with quinine for treating uncomplicated malaria in a village dispensary in Gabon. Trop. Med. Int. Hlth. 1997; 2:917-919.